首页 | 本学科首页   官方微博 | 高级检索  
     

放疗相关因素对伴恶性胸腔积液非小细胞肺癌生存的影响
引用本文:李青松,欧阳伟炜,苏胜发,马筑,耿一超,杨文刚,胡银祥,栗蕙芹,李晓阳,陈霞霞,卢冰. 放疗相关因素对伴恶性胸腔积液非小细胞肺癌生存的影响[J]. 中华放射肿瘤学杂志, 2021, 30(2): 120-126. DOI: 10.3760/cma.j.cn113030-20201026-00517
作者姓名:李青松  欧阳伟炜  苏胜发  马筑  耿一超  杨文刚  胡银祥  栗蕙芹  李晓阳  陈霞霞  卢冰
作者单位:贵州医科大学附属医院胸部肿瘤科贵州医科大学肿瘤学教研室贵州省肿瘤医院肿瘤科,贵阳 550004
摘    要:
目的:回顾分析伴恶性胸腔积液(MPE)的非小细胞肺癌(NSCLC)原发灶放疗相关因素对生存影响。方法:2007—2019年间经病理学证实、初治的伴MPE的NSCLC共256例,其中117例纳入分析。按放疗剂量<63 Gy与≥63 Gy分为2个组,采用倾向性评分匹配法均衡组间混杂因素(卡钳值=0.1)。 Ka...

关 键 词:恶性胸腔积液  肺肿瘤/放射疗法  放射疗法,调强  预后
收稿时间:2020-10-26

Impact of radiotherapy-related factors on survival in non-small cell lung cancer complicated with malignant pleural effusion based on propensity score matching
Li Qingsong,Ouyang Weiwei,Su Shengfa,Ma Zhu,Geng Yichao,Yang Wengang,Hu Yinxiang,Li Huiqin,Li Xiaoyang,Chen Xiaxia,Lu Bing. Impact of radiotherapy-related factors on survival in non-small cell lung cancer complicated with malignant pleural effusion based on propensity score matching[J]. Chinese Journal of Radiation Oncology, 2021, 30(2): 120-126. DOI: 10.3760/cma.j.cn113030-20201026-00517
Authors:Li Qingsong  Ouyang Weiwei  Su Shengfa  Ma Zhu  Geng Yichao  Yang Wengang  Hu Yinxiang  Li Huiqin  Li Xiaoyang  Chen Xiaxia  Lu Bing
Affiliation:Department of Thoracic Oncology, Affiliated Hospital of Guizhou Medical University, and Guizhou Cancer Hospital, Guiyang, Teaching and Research Section of Oncology, Guizhou Medical University, Guiyang 550004, China
Abstract:
Objective To analyze the radiotherapy-related factors affecting the survival of non-small cell lung cancer (NSCLC) patients complicated with malignant pleural effusion (MPE)(MPE-NSCLC). Methods From 2007 to 2019, 256 patients pathologically diagnosed with MPE-NSCLC received primary treatment. Among them, 117 cases were enrolled in this study. All patients were divided into two groups according to the radiation dose (<63Gy and≥63Gy). Propensity score matching (PSM) was performed to further adjust the confounding factors (Calipers value=0.1). The impact of radiotherapy-related factors on the overall survival (OS) was analyzed by Kaplan—Meier method, log-rank test and Cox’s regression model. Results Primary tumor radiotherapy significantly prolonged the OS (P<0.001). The radiation dose escalation (36.0-44.1Gy, 45.0-62.1Gy, 63.0-71.1Gy) of primary tumor significantly prolonged the OS (P<0.001). The corresponding median OS were 5, 13 and 18 months, respectively. Before the PSM,univariate analysis suggested that radiation dose ≥63Gy, gross tumor volume (GTV)<157.7cm3 and stations of metastatic lymph node (S-mlN)≤5 were significantly associated with better OS (all P<0.05) and T4N3 was significantly associated with worse OS (P=0.018). After the PSM,univariate analysis indicated that radiation dose ≥63Gy was significantly associated with better OS (P=0.013) and S-mlN ≤5had a tendency to prolong the OS (P=0.098). Prior to the PSM, multivariate analysis showed that radiation dose ≥63Gy was an independent favorable factor of OS (HR=0.566,95%CI 0.368-0.871,P=0.010) and GTV<157.7cm3had a tendency to prolong the OS (HR=0.679,95%CI 0.450-1.024,P=0.065). After the PSM, multivariate analysis revealed that radiation dose ≥63Gy was still an independent favorable factor of OS (HR=0.547,95%CI 0.333~0.899,P=0.017). No ≥grade 4 radiation toxicity occurred. The incidence rates of grade 3 radiation esophagitis and pneumonitis were 9.4% and 5.1%, respectively. Conclusion For MPE-NSCLC, radiotherapy dose of primary tumor may play a key role in improving OS on the basis of controllable MPE.
Keywords:Malignant pleural effusion  Lung neoplasm/radiotherapy  Radiotherapy  intensity-modulated  Prognosis  
点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息
点击此处可从《中华放射肿瘤学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号